InterCure (NASDAQ:INCR) Shares Up 0.5%

InterCure Ltd. (NASDAQ:INCR) shares shot up 0.5% on Tuesday . The stock traded as high as $2.18 and last traded at $2.13. 19,969 shares changed hands during trading, a decline of 68% from the average session volume of 62,230 shares. The stock had previously closed at $2.12.

InterCure Stock Performance

The company has a current ratio of 1.85, a quick ratio of 1.38 and a debt-to-equity ratio of 0.23. The firm’s 50-day moving average is $2.16 and its two-hundred day moving average is $2.38. The stock has a market cap of $102.08 million, a price-to-earnings ratio of 17.23 and a beta of 1.51.

Institutional Trading of InterCure

A number of hedge funds have recently bought and sold shares of INCR. Renaissance Technologies LLC increased its holdings in shares of InterCure by 30.9% during the 2nd quarter. Renaissance Technologies LLC now owns 45,300 shares of the company’s stock worth $91,000 after buying an additional 10,700 shares during the last quarter. AdvisorShares Investments LLC purchased a new position in shares of InterCure during the 2nd quarter worth approximately $218,000. Finally, Tidal Investments LLC purchased a new position in shares of InterCure during the 1st quarter worth approximately $883,000. Institutional investors and hedge funds own 8.34% of the company’s stock.

InterCure Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.